These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7907608)

  • 41. Abnormal expression of growth regulatory factors in Barrett's oesophagus.
    Jankowski J; McMenemin R; Hopwood D; Penston J; Wormsley KG
    Clin Sci (Lond); 1991 Nov; 81(5):663-8. PubMed ID: 1661653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus.
    Tajima Y; Nakanishi Y; Yoshino T; Kokawa A; Kusano M; Shimoda T
    Oncology; 2001; 61(1):1-9. PubMed ID: 11474241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation.
    Cen P; Correa AM; Lee JH; Maru D; Anandasabapathy S; Liao Z; Hofstetter WL; Swisher SG; Komaki R; Ross WA; Vaporciyan A; Ajani JA
    Dis Esophagus; 2009; 22(1):32-41. PubMed ID: 19021684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus.
    Couvelard A; Paraf F; Vidaud D; Dubois S; Vidaud M; Fléjou JF; Degott C
    Virchows Arch; 2004 Sep; 445(3):279-84. PubMed ID: 15309632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
    Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
    Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
    De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
    Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas.
    al-Kasspooles M; Moore JH; Orringer MB; Beer DG
    Int J Cancer; 1993 May; 54(2):213-9. PubMed ID: 8098013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma.
    Brundler MA; Harrison JA; de Saussure B; de Perrot M; Pepper MS
    J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction.
    Yamada M; Kushima R; Oda I; Mojtahed K; Nonaka S; Suzuki H; Yoshinaga S; Matsubara A; Taniguchi H; Sekine S; Saito Y; Shimoda T
    Jpn J Clin Oncol; 2014 Jan; 44(1):65-71. PubMed ID: 24220802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
    Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
    Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dna ploidy in adenocarcinoma of Barrett's esophagus].
    Flejou JF; Doublet B; Potet F; Metayer J; Hemet J
    Ann Pathol; 1990; 10(3):161-5. PubMed ID: 2386598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of lifestyle on Barrett's Esophagus: A precursor to esophageal adenocarcinoma.
    Navab F; Nathanson BH; Desilets DJ
    Cancer Epidemiol; 2015 Dec; 39(6):885-91. PubMed ID: 26519660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barrett's esophagus-is it bad for your health?
    Falk GW
    Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus.
    Polkowski W; van Lanschot JJ; ten Kate FJ; Rolf TM; Polak M; Tytgat GN; Obertop H; Offerhaus GJ
    Am J Gastroenterol; 2000 Mar; 95(3):617-25. PubMed ID: 10710048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
    Duhaylongsod FG; Wolfe WG
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
    Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
    Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Endoscopic diagnosis of Barrett's adenocarcinoma].
    Yoshio H; Takashi Y; Mitsuyo H; Nobuhiko Y; Tatsurou T; Kazuhiko S; Yoko H; Shigemasa I; Hisanaga M; Osamu H; Katsuyoshi S; Seishi U; Matsushita H; Masahiko T
    Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):244-8. PubMed ID: 10379534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.